Literature DB >> 3383395

Lifetime risk for patients with mitral valve prolapse of developing severe valve regurgitation requiring surgery.

D E Wilcken1, A J Hickey.   

Abstract

Severe mitral regurgitation requiring surgery is the most common life-threatening complication of mitral valve prolapse (MVP) and is due to progressive myxomatous change in the valve. We identified all residents of New South Wales, Australia, who had mitral valve surgery for myxomatous valve disease during 1982 and, using these data and the adult population statistics from 1982, estimated the cumulative risk of valve surgery in patients with MVP. In 1982, 50 of the 5.36 million New South Wales residents required surgery for this complication of MVP. Of the 50, 36 were men and 14 were women, which was significantly different from the population sex distribution (p less than 0.02) for mean age +/- SD of 60 +/- 11 years (range, 26-78 years). Using our previously determined 4% prevalence of adult MVP in New South Wales, we estimated the number of male and female patients with MVP at risk for each 5-year age interval and calculated age-specific event rates. The results show that the cumulative risk is minimal below the age of 50 years but then rises steeply, particularly in men. The risks in men aged 50, 60, and 70 years (with 95% confidence intervals) were 1:202 (130-448), 1:53 (37-82), and 1:28 (22-41), respectively. In women, the risk was less than half that in men (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3383395     DOI: 10.1161/01.cir.78.1.10

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Cardiology.

Authors:  L D Smith; D J Coltart
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

Review 2.  The long-term outcome of mitral valve repair for mitral valve prolapse.

Authors:  Dania Mohty; Maurice Enriquez-Sarano
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

3.  Echocardiographic abnormalities in type IV mucopolysaccharidosis.

Authors:  R M John; D Hunter; R H Swanton
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

4.  Mitral Valve Chordae Tendineae: Topological and Geometrical Characterization.

Authors:  Amir H Khalighi; Andrew Drach; Charles H Bloodworth; Eric L Pierce; Ajit P Yoganathan; Robert C Gorman; Joseph H Gorman; Michael S Sacks
Journal:  Ann Biomed Eng       Date:  2016-12-19       Impact factor: 3.934

5.  Marfan syndrome and mitral valve prolapse.

Authors:  Arthur E Weyman; Marielle Scherrer-Crosbie
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

6.  Secundum atrial septal defect repair: long-term surgical outcome and the problem of late mitral regurgitation.

Authors:  M E Speechly-Dick; R John; W B Pugsley; M F Sturridge; R H Swanton
Journal:  Postgrad Med J       Date:  1993-12       Impact factor: 2.401

Review 7.  Mitral Valve Prolapse in Pregnancy.

Authors:  Shi-Min Yuan; Song-Li Yan
Journal:  Braz J Cardiovasc Surg       Date:  2016-04

8.  Mitral valve repair, how to make volume not matter; techniques, tendencies, and outcomes, a single center experience.

Authors:  Manuel Giraldo-Grueso; Néstor Sandoval-Reyes; Jaime Camacho; Ivonne Pineda; Juan P Umaña
Journal:  J Cardiothorac Surg       Date:  2018-10-16       Impact factor: 1.637

9.  Risk of Mitral Valve Prolapse in Patients with Keratoconus in Taiwan: A Population-Based Cohort Study.

Authors:  Yuh-Shin Chang; Ming-Cheng Tai; Shih-Feng Weng; Jhi-Joung Wang; Sung-Huei Tseng; Ren-Long Jan
Journal:  Int J Environ Res Public Health       Date:  2020-08-20       Impact factor: 3.390

10.  New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study.

Authors:  Thierry Le Tourneau; Solena Le Scouarnec; Caroline Cueff; Daniel Bernstein; Jan J J Aalberts; Simon Lecointe; Jean Mérot; Jonathan A Bernstein; Toon Oomen; Christian Dina; Matilde Karakachoff; Hubert Desal; Ousama Al Habash; Francesca N Delling; Romain Capoulade; Albert J H Suurmeijer; David Milan; Russell A Norris; Roger Markwald; Elena Aikawa; Susan A Slaugenhaupt; Xavier Jeunemaitre; Albert Hagège; Jean-Christian Roussel; Jean-Noël Trochu; Robert A Levine; Florence Kyndt; Vincent Probst; Hervé Le Marec; Jean-Jacques Schott
Journal:  Eur Heart J       Date:  2018-04-14       Impact factor: 35.855

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.